Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents [language] = "en-us"

Di |2021-10-20T23:00:00+02:00Ottobre 20th, 2021|Categorie: Coronavirus NEJM|

To the Editor: The B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as the dominant strain circulating in many regions worldwide. The BNT162b2 mRNA vaccine against coronavirus disease 2019 (Covid-19)...